OpenVSafe by OpenVAERS
Search V-safe

ZUX-17895-65182

3 vaccinations 4 coded responses 15 check-ins 4 free-text entries 0 call cases
Sex
Female
Age at first dose
05-11
ZIP prefix
981 / WA
Registered
2022-06-06
Relationship
Child or adolescent in my care
Guardian
7ZC-84751-02989
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-11-18
    Dose 1 — Pfizer-BioNTech
  2. 2021-12-09
    Dose 2 — Pfizer-BioNTech
  3. 2022-06-05
    Dose 3 — Pfizer-BioNTech
  4. 2022-06-06
    Registered in v-safe
  5. 2022-06-06
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Poor · Site: Pain · Fever · Chills, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  6. 2022-06-07
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Fair · Fatigue or tiredness, Vomiting · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  7. 2022-06-08
    Survey response — days 1–6 daily, dose 3, dependent
    MedDRA: Rhinorrhoea — Feeling: Good
    Free text: Runny nose
    MedDRA releases: 2024-11 · check-in free text available
  8. 2022-06-09
    Survey response — days 1–6 daily, dose 3, dependent
    MedDRA: Cough, Rhinorrhoea — Feeling: Good
    Free text: Mild runny nose and cough
    MedDRA releases: 2024-11 · check-in free text available
  9. 2022-06-10
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  10. 2022-06-11
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  11. 2022-06-14
    Health check-in — day 7, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  12. 2022-06-21
    Health check-in — day 14, dose 3, dependent
    Feeling: Good
    Adult check-in
  13. 2022-06-26
    Health check-in — day 21, dose 3, dependent
    Feeling: Good
    Adult check-in
  14. 2022-07-03
    Survey response — day 28, dose 3, dependent
    MedDRA: Nasal congestion, Pre-existing disease, Rhinorrhoea — Feeling: Good
    Free text: Stuffy and runny nose, probably just allergies
    MedDRA releases: 2024-11 · check-in free text available
  15. 2022-07-10
    Survey response — day 35, dose 3, dependent
    MedDRA: Pre-existing disease, Rhinorrhoea — Feeling: Good
    Free text: Runny nose, again, likely allergies
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-07-17
    Health check-in — day 42, dose 3, dependent
    Feeling: Good
    Adult check-in
  17. 2022-09-04
  18. 2022-12-04
  19. 2023-06-05

Vaccinations

DoseDateManufacturerCo-administered
12021-11-18Pfizer-BioNTech No
22021-12-09Pfizer-BioNTech No
32022-06-05Pfizer-BioNTech No

Free text

Release 11 — days 1–6 daily, dose 3, dependent

2022-06-08

Systemic reaction (other): Runny nose

Release 12 — days 1–6 daily, dose 3, dependent

2022-06-09

Systemic reaction (other): Mild runny nose and cough

Release 12 — day 28, dose 3, dependent

2022-07-03

Symptoms: Stuffy and runny nose, probably just allergies

Release 12 — day 35, dose 3, dependent

2022-07-10

Symptoms: Runny nose, again, likely allergies

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDNasal congestion · · ✓
SDPre-existing disease · · ✓
SDRhinorrhoea · · ✓
SROCough · · ✓
SRORhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release